EXHIBIT A SECURITIES PURCHASE AGREEMENT and escrow agreement MDNA Life Sciences, Inc. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 5th, 2022 • MDNA Life Sciences, Inc. • In vitro & in vivo diagnostic substances • Delaware
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made as of the ___ day of _________________, 2018 by and among MDNA Life Sciences, Inc., a Delaware corporation (the “Company”), and the purchasers identified on the signature page hereto (each a “Purchaser” and together the “Purchasers”).
DATED 21 March 2019Lease • August 5th, 2022 • MDNA Life Sciences, Inc. • In vitro & in vivo diagnostic substances • England and Wales
MDNA LIFE SCIENCES (UK) LIMITED (company number 05386828) whose registered office is at 83 Kingfisher House, Kingsway, Team Valley, Gateshead, Tyne & Wear NE11 OJQ
FIRST AMENDMENT TO DECEMBER 22, 2017 LICENSE AGREEMENTLicense Agreement • August 5th, 2022 • MDNA Life Sciences, Inc. • In vitro & in vivo diagnostic substances
THIS First Amendment to the December 22, 2017 License Agreement ("First Amendment"), effective as of the date last written below (the "Effective Date"), is made by and between MDNA Life Sciences Inc. ("MDNA") and Laboratory Corporation of America Holdings ("LabCorp"). MDNA and LabCorp may be referred to herein each as a "Party" or collectively as "Parties."
SECOND AMENDMENT TO DECEMBER 22, 2017 LICENSE AGREEMENTLicense Agreement • August 5th, 2022 • MDNA Life Sciences, Inc. • In vitro & in vivo diagnostic substances
THIS Second Amendment to the December 22, 2017 License Agreement ("Second Amendment"), effective as of the date of execution by both parties (the "Effective Date"), is made by and between MDNA Life Sciences Inc. ("MDNA") and Laboratory Corporation of America Holdings ("LabCorp"). LabCorp and MDNA may be referred to herein each as a "Party" or collectively as "Parties."
LICENSE AGREEMENTLicense Agreement • August 5th, 2022 • MDNA Life Sciences, Inc. • In vitro & in vivo diagnostic substances • Delaware
This License Agreement ("Agreement") is entered into by and between MDNA Life Sciences Inc., a Delaware corporation ("MDNA"), and Laboratory Corporation of America Holdings, a Delaware corporation ("LabCorp"), as of the 22nd day of December, 2017 (the "Effective Date").
